-
公开(公告)号:US20240352107A1
公开(公告)日:2024-10-24
申请号:US18685718
申请日:2022-09-15
Applicant: H. LUNDBECK A/S
Inventor: Roger K. CADY , Joseph HIRMAN , Carlton ANDERSON , Elizabeth BRUNNER
CPC classification number: C07K16/18 , A61P25/06 , A61K2039/505 , A61K2039/545 , C07K2317/24
Abstract: The present invention relates the use of monoclonal anti-calcitonin gene-related peptide (CGRP) antagonist antibodies or anti-CGRP receptor antibodies in subjects that do not respond adequately to a first dose but respond to the second dose.